VVOS Insider Trading

Insider Ownership Percentage: 3.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Vivos Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Vivos Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20k-$10k$0$10k$20kTotal Insider BuyingTotal Insider Selling

Vivos Therapeutics Share Price & Price History

Current Price: $2.57
Price Change: Price Decrease of -0.06 (-2.28%)
As of 04/2/2025 05:00 PM ET

This chart shows the closing price history over time for VVOS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$2.63Closing price on 04/01/25:

Vivos Therapeutics Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Vivos Therapeutics (NASDAQ:VVOS)

26.35% of Vivos Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VVOS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$775kbought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$5M$0$5MTotal InflowsTotal Outflows
Vivos Therapeutics logo
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.
Read More on Vivos Therapeutics

Today's Range

Now: $2.57
Low: $2.38
High: $2.74

50 Day Range

MA: $3.66
Low: $2.63
High: $5.03

52 Week Range

Now: $2.57
Low: $1.91
High: $6.28

Volume

160,032 shs

Average Volume

471,771 shs

Market Capitalization

$15.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

7.47

Who are the company insiders with the largest holdings of Vivos Therapeutics?

Vivos Therapeutics' top insider investors include:
  1. Ronald Kirk Huntsman (CEO)
Learn More about top insider investors at Vivos Therapeutics.